Major Adverse Cardiovascular Events During Invasive Pneumococcal Disease Are Serotype Dependent
Author(s) -
Hector F. Africano,
Cristian C. Serrano-Mayorga,
Paula C. Ramirez-Valbuena,
Ingrid G. Bustos,
Alirio Bastidas,
Hernán Vargas,
Sandra L. GomezPerez,
Alejandro Rodríguez,
Carlos J. Orihuela,
Luis Felipe Reyes
Publication year - 2020
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa1427
Subject(s) - mace , medicine , bacteremia , retrospective cohort study , streptococcus pneumoniae , serotype , myocardial infarction , odds ratio , community acquired pneumonia , confidence interval , pneumonia , immunology , percutaneous coronary intervention , microbiology and biotechnology , antibiotics , biology
Up to 30% of patients admitted to hospitals with invasive pneumococcal disease (IPD) experience major adverse cardiovascular event (MACE) including new/worsening heart failure, new/worsening arrhythmia, and/or myocardial infarction. Streptococcus pneumoniae (Spn) is the most frequently isolated bacterial pathogen among community-acquired pneumonia (CAP) patients and the only etiological agent linked independently to MACE. Nevertheless, no clinical data exist identifying which serotypes of Spn are principally responsible for MACE.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom